Department of Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Neoplasm Metastasis 63%
3. Prostatic Neoplasms 54%
4. Taiwan 43%
5. Carcinoma 35%
6. Skin 32%
7. Human Herpesvirus 4 31%
8. Neoplastic Stem Cells 30%
9. Breast Neoplasms 29%
10. Nasopharyngeal Carcinoma 29%
11. Colorectal Neoplasms 28%
12. Hepatocellular Carcinoma 26%
13. Therapeutics 26%
14. Down-Regulation 23%
15. Bone and Bones 23%
16. Growth 23%
17. Stomach Neoplasms 22%
18. Survival 21%
19. ErbB Receptors 21%
20. Stomach 20%
21. Recurrence 20%
22. Epithelial-Mesenchymal Transition 20%
23. MicroRNAs 19%
24. Catenins 19%
25. Toxocara canis 19%
26. Lymph Nodes 18%
27. Pharmaceutical Preparations 18%
28. Biomarkers 17%
29. Proteins 17%
30. Colonic Neoplasms 17%
31. In Vitro Techniques 17%
32. Drug Therapy 16%
33. Carcinogenesis 16%
34. Androgens 16%
35. Lymphoma 16%
36. Genes 15%
37. Breast 15%
38. Glioblastoma 15%
39. Magnetic Resonance Imaging 15%
40. Cell Proliferation 15%
41. Phenotype 14%
42. Biopsy 14%
43. glucose-regulated proteins 14%
44. Cell Line 14%
45. Sarcoma 14%
46. Staining and Labeling 14%
47. Lung Neoplasms 14%
48. Helicobacter pylori 14%
49. Heterografts 13%
50. Up-Regulation 13%
51. Squamous Cell Carcinoma 13%
52. Protein-Tyrosine Kinases 13%
53. Skin Absorption 13%
54. Cisplatin 13%
55. Bone Neoplasms 12%
56. Triple Negative Breast Neoplasms 12%
57. Castration 12%
58. Peripheral T-Cell Lymphoma 12%
59. Adenocarcinoma 12%
60. Liver 12%
61. Ovarian Neoplasms 11%
62. 4-acetylantroquinonol B 11%
63. Cell Movement 11%
64. Prostate 11%
65. Glioma 11%
66. Androgen Receptors 11%
67. pterostilbene 11%
68. Solid-State Lasers 11%
69. Mutation 11%
70. Marginal Zone B-Cell Lymphoma 11%
71. Epstein-Barr virus EBV-associated membrane antigen 10%
72. Lung 10%
73. Squamous Cell Carcinoma of Head and Neck 10%
74. Neck 10%
75. Adenocarcinoma of Lung 10%
76. Transforming Growth Factors 10%
77. Messenger RNA 10%
78. T-Cell Lymphoma 10%
79. Stem Cells 10%
80. Epidermal Growth Factor 10%
81. Immunohistochemistry 10%
82. hydroquinone 9%
83. Primary Effusion Lymphoma 9%
84. Disease-Free Survival 9%
85. Nude Mice 9%
86. Membrane Proteins 9%
87. Bariatric Surgery 9%
88. Nitric Oxide Synthase Type II 9%
89. Nanoparticles 9%
90. Magnetic Resonance Spectroscopy 9%
91. Endoscopic Mucosal Resection 9%
92. Radiotherapy 8%
93. osteoblast cadherin 8%
94. Apoptosis 8%
95. Renal Cell Carcinoma 8%
96. Phosphotransferases 8%
97. Pylorus 8%
98. Cell Cycle 8%
99. Collagen 8%
100. Epigenomics 8%